Abstract
Hyperglycemia-induced oxidative stress accelerates endothelial cell dysfunctions, which cause various complications of diabetes. The protective effects of 6,6′-bieckol (BEK), one of phlorotannin compound purified from Ecklonia cava against high-glucose-induced oxidative stress was investigated using human umbilical vein endothelial cells (HUVECs), which is susceptible to oxidative stress. High glucose (30 mM) treatment induced HUVECs’ cell death, but BEK, at concentration 10 or 50 μg/ml, significantly inhibited the high-glucose-induced cytotoxicity. Furthermore, treatment with BEK dose-dependently decreased thiobarbituric acid reactive substances (TBARS), intracellular reactive oxygen species (ROS) generation, and nitric oxide level increased by high glucose. In addition, high glucose levels induced the overexpressions of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and nuclear factor-kappa B (NF-κB) proteins in HUVECs, but BEK treatment reduced the overexpressions of these proteins. These findings indicate that BEK is a potential therapeutic agent that will prevent diabetic endothelial dysfunction and related complications.
Similar content being viewed by others
References
Zimmet, P., Alberti, K., & Shaw, J. (2001). Nature, 414, 782–787.
Baron, A. D. (1998). Diabetes Reserch and Clinical Practice, 40, S51–S55.
Van Dam, P. S., Van Asbeck, B. S., Van Oirschot, J. F., Biessels, G. J., Hamers, F. P., & Marx, J. J. (2001). European Journal of Clinical Investigation, 31, 417–424.
Feldman, E. F. (2003). Journal of Clinical Investigation, 111, 431–433.
Hiramatsu, K., & Arimori, S. (1998). Diabetes, 37, 832–837.
Dewanjee, S., Das, A. K., Sahu, R., & Gangopadhyay, M. (2009). Food and Chemical Toxicology, 47, 2679–2685.
Morigi, M., Angioletti, S., Imberti, B., Donatelli, R., Micheletti, G., Figliuzzi, M., et al. (1998). Journal of Clinical Investigation, 101, 1905–1915.
Yokozawa, T., Kim, Y. A., Kim, H. Y., Lee, Y. A., & Nonaka, G. (2007). Food and Chemical Toxicology, 45, 1979–1987.
Lee, S. H., Han, J. S., Heo, S. J., Hwang, J. Y., & Jeon, Y. J. (2010). Toxicology In Vitro, 24, 375–381.
Ahn, G. N., Kim, K. N., Cha, S. H., Song, C. B., Lee, J. H., Heo, M. S., et al. (2007). European Food Research and Technology, 226, 71–79.
Le, Q. T., Li, Y., Qian, Z. J., Kim, M. M., & Kim, S. K. (2008). Process Biochemistry, 44, 168–176.
Ahn, M. J., Yoon, K. D., Min, S. Y., Lee, J. S., Kim, J. H., Kim, T. G., et al. (2004). Biological & Pharmaceutical Bulletin, 27, 544–547.
Lee, S. H., Park, M. H., Heo, S. J., Kang, S. M., KO, S. C., Han, J. S., et al. (2010). Food and Chemical Toxicology, 48, 2633–2637.
Kang, S. M., Heo, S. J., Kim, K. N., Lee, S. H., & Jeon, Y. J. (2012). Journal of Functional Foods, 4, 158–166.
Kang, S. M., Lee, S. H., Heo, S. J., Kim, K. N., & Jeon, Y. J. (2011). Nutrition Research Practice, 5, 495–502.
Fautz, R., Husen, B., & Hechenberger, C. (1991). Mutation Research, 253, 173–179.
Wang, H., & Joseph, J. A. (1999). Free Radical Biology and Medicine, 27, 612–616.
Fraga, C. G., Leibovita, R. M., & Roeder, R. G. (1988). Free Radical Biology and Medicine, 4, 155–161.
Nath, J., & Powledge, A. (1997). Journal of Leukocyte Biology, 62, 805–816.
Yamabe, N., Kang, K. S., Goto, E., Tanaka, T., & Yokozawa, T. (2007). Biological & Pharmaceutical Bulletin, 30, 520–526.
Uemura, S., Matsushita, H., Li, W., Glassford, A. J., Asagami, T., Lee, K. H., et al. (2001). Circulation Research, 88, 1291–1298.
Finkel, T. N., & Holbrook, J. (2000). Nature, 408, 239–247.
Lee, Y. J., Kang, D. G., Kim, J. S., & Lee, H. S. (2008). Vascular Pharmacology, 48, 38–46.
Sevanian, A., & Hochstein, P. (1985). Annual Review of Nutrition, 5, 365–390.
Bucula, R. (1991). Journal of Clinical Investigation, 87, 432–438.
Schmidtmann, S., Muller, M., von Baehr, R., & Precht, K. (1991). Nephrology, Dialysis, Transplantation, 6, 71–74.
Seghrouchni, I., Drai, J., Bannier, E., Riviere, J., Calmard, P., Garcia, I., et al. (2002). Clinica Chimica Acta, 321, 89–96.
Radi, R., Beckman, J. S., Bush, K. M., & Freeman, B. A. (1991). Archives of Biochemistry and Biophysics, 288, 481–487.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991). Pharmacological Reviews, 43, 109–142.
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990). Proceedings of the National Academy Sciences of the United States of America, 87, 1620–1624.
Spencer, N. F., Poynter, M. E., Im, S. Y., & Daynes, R. A. (1997). International Immunology, 9, 1581–1588.
Wu, K. K. (1995). Advances in Pharmacology, 33, 179–190.
Baeuerle, P. A., & Baltimore, D. (1996). Cell, 87, 13–20.
Han, M., Wen, J. K., Zheng, B., & Zhang, D. Q. (2004). Life Sciences, 75, 675–684.
Du, X., Stocklauser-Farber, K., & Rosen, P. (1999). Free Radical Biology and Medicine, 27, 752–763.
Hattori, Y., Hattori, S., Sato, N., & Kasai, K. (2000). Cardiovascular Research, 46, 188–197.
Acknowledgments
This research was also supported by the research programs of the Korea Institute of Ocean Science and Technology (PE99214). This research was supported by a grant from Marine Biotechnology Program Funded by Ministry of Oceans and Fisheries, Korea (PM 57770).
Author information
Authors and Affiliations
Corresponding author
Additional information
Mi-Hwa Park and Soo-Jin Heo contributed equally to this work.
Rights and permissions
About this article
Cite this article
Park, MH., Heo, SJ., Park, PJ. et al. 6,6′-Bieckol Isolated from Ecklonia cava Protects Oxidative Stress Through Inhibiting Expression of ROS and Proinflammatory Enzymes in High-Glucose-Induced Human Umbilical Vein Endothelial Cells. Appl Biochem Biotechnol 174, 632–643 (2014). https://doi.org/10.1007/s12010-014-1099-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-014-1099-4